» Articles » PMID: 35746659

Gastrointestinal Involvement in SARS-CoV-2 Infection

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2022 Jun 24
PMID 35746659
Authors
Affiliations
Soon will be listed here.
Abstract

SARS-CoV-2 has evolved into a virus that primarily results in mild or asymptomatic disease, making its transmission more challenging to control. In addition to the respiratory tract, SARS-CoV-2 also infects the digestive tract. Some gastrointestinal symptoms occur with or before respiratory symptoms in patients with COVID-19. Respiratory infections are known to cause intestinal immune impairment and gastrointestinal symptoms. When the intestine is inflamed, cytokines affect the lung immune response and inflammation through blood circulation. The gastrointestinal microbiome may be a modifiable factor in determining the risk of SARS-CoV-2 infection and disease severity. The development of oral SARS-CoV-2 vaccine candidates and the maintenance of gut microbiota profiles may contribute to the early control of COVID-19 outbreaks. To this end, this review summarizes information on the gastrointestinal complications caused by SARS-CoV-2, SARS-CoV-2 infection, the gastrointestinal-lung axis immune response, potential control strategies for oral vaccine candidates and maintaining intestinal microbiota homeostasis.

Citing Articles

Overview of the Trending Enteric Viruses and Their Pathogenesis in Intestinal Epithelial Cell Infection.

Chio C, Chien J, Chan H, Huang H Biomedicines. 2025; 12(12.

PMID: 39767680 PMC: 11672972. DOI: 10.3390/biomedicines12122773.


The Intestine in Acute and Long COVID: Pathophysiological Insights and Key Lessons.

Zollner A, Meyer M, Jukic A, Adolph T, Tilg H Yale J Biol Med. 2024; 97(4):447-462.

PMID: 39703608 PMC: 11650913. DOI: 10.59249/PMIE8461.


Before Gastrointestinal Symptoms in Students Can Be Attributed to Anxiety and Depression during the Lockdown, Alternative Causes Must Be Ruled Out [Letter].

Finsterer J Neuropsychiatr Dis Treat. 2024; 20:1613-1614.

PMID: 39188654 PMC: 11346473. DOI: 10.2147/NDT.S481455.


Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER program.

Varma J, Zang C, Carton T, Block J, Khullar D, Zhang Y PLoS One. 2024; 19(6):e0282451.

PMID: 38843159 PMC: 11156291. DOI: 10.1371/journal.pone.0282451.


Upregulation of mRNA Expression of ADGRD1/GPR133 and ADGRG7/GPR128 in SARS-CoV-2-Infected Lung Adenocarcinoma Calu-3 Cells.

Zackova S, Pavova M, Trylcova J, Chalupova J, Priss A, Luksan O Cells. 2024; 13(10.

PMID: 38786015 PMC: 11119037. DOI: 10.3390/cells13100791.


References
1.
Cheung C, Poon L, Ng I, Luk W, Sia S, Wu M . Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol. 2005; 79(12):7819-26. PMC: 1143636. DOI: 10.1128/JVI.79.12.7819-7826.2005. View

2.
Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J . Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. Am J Gastroenterol. 2020; 115(5):766-773. PMC: 7172492. DOI: 10.14309/ajg.0000000000000620. View

3.
Sims A, Baric R, Yount B, Burkett S, Collins P, Pickles R . Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol. 2005; 79(24):15511-24. PMC: 1316022. DOI: 10.1128/JVI.79.24.15511-15524.2005. View

4.
Zhang T, Liu D, Tian D, Xia L . The roles of nausea and vomiting in COVID-19: did we miss something?. J Microbiol Immunol Infect. 2021; 54(4):541-546. PMC: 7568482. DOI: 10.1016/j.jmii.2020.10.005. View

5.
Wrapp D, Wang N, Corbett K, Goldsmith J, Hsieh C, Abiona O . Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020; 367(6483):1260-1263. PMC: 7164637. DOI: 10.1126/science.abb2507. View